~~<i id='12579E5A29'><strike id='12579E5A29'><tt id='12579E5A29'><pre id='12579E5A29'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

entertainment

author：fashion 2025-10-01 04:09:56 - browse：19

A box of Sudafed PE sinus pressure and pain medicine. -- health coverage from stat — PATRICK T. FALLON/AFP via Getty Images

You would have been forgiven for being surprised on Sept. 12 when a panel of advisers to the Food and Drug Administration concluded that the active ingredient in Sudafed PE and other over-the-counter decongestants is completely ineffective. It was front-page news, birthed myriad explainer stories on the internet, and even inspired a lawsuit against companies that sold the medicine, phenylephrine.

Yet when T.J. Parker, the entrepreneur and pharmacist who sold PillPack to Amazon, saw the news, he tweeted, “Didn’t everyone know this?”

He had a point.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Physicians aren't 'burning out.' They're suffering from moral injury

hotspot

knowledge

focus

Wikipedia

entertainment

focus

Rep.LarryBucshon(R-Ind.)receivedasignificantamountofcampaigndonationsfromthepharmaceuticalindustryin

WSS

FDA scientists endorse Pfizer/BioNTech Covid

Medicare slashes safety net hospital payments by nearly $1 billion

To avoid data mishandling cases, universities eye AI and other tools

How to ethically and practically extend health care to all

Why did Pfizer dish out millions for a Super Bowl ad?

Late stage cancers on the rise after pandemic delayed screenings

leisure time

entertainment

hotspot

Medicare details structure of new drug price negotiation program

Group behind ProMed defends move to subscription

Medical records are filled with copy

The dental labor crisis is a moment of opportunity

Alkermes shareholders re

Alnylam reports growth in sales of rare disease treatments

Heart attack and stroke risk calculators need revising

Private equity deals in Medicare Advantage declines

Trump demands the U.S. pay no more for drugs than other countries … again

Chris Christie meets with Zelenskyy during Ukraine trip

knowledge

Study links childhood stress with decline in older age

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

Medicare threatens to cut off funding for HCA's Mission hospital

Biotech startup Celsius cuts 75% of staff ahead of first trial start

A disappointing year of Humira biosimilars

How I helped Pfizer think through the ethics of Viagra

focus

Wikipedia

entertainment

focus